Jin Yanliang, Chief Physician, Master's Supervisor, Chief Expert in the Department of Rheumatology and Immunology Primarily engaged in the diagnosis and treatment of pediatric rheumatic and immunologic diseases, with expertise in systemic lupus erythematosus, Henoch-Schönlein purpura/purpura nephritis, juvenile idiopathic arthritis, juvenile dermatomyositis/polymyositis, Sjögren's syndrome, mixed connective tissue disease, panniculitis, Takayasu arteritis, Behçet's disease, and rare diseases such as monogenic autoinflammatory disorders. He is particularly skilled in the diagnosis and management of complex and critical conditions associated with pediatric rheumatic diseases, including interstitial lung disease, macrophage activation syndrome, and central nervous system lupus. Currently serves as a member of the Rheumatology Group of the Pediatrics Branch of the Chinese Medical Association, Head of the Pediatric Group of the Rheumatology Committee of the Shanghai Integrated Traditional Chinese and Western Medicine Association, Deputy Head of the Immunology Group of the Pediatrics Branch of the Shanghai Medical Association, and a member of the Shanghai Rheumatology and Immunology Society. He is also an editorial board member for the Journal of Clinical Pediatrics, the Chinese Journal of Practical Pediatrics, and the International Journal of Pediatrics. Overseas training: Previously conducted observational study at the Department of Rheumatology, Cincinnati Children's Hospital, USA. Main research directions: Investigating the pathogenesis of Henoch-Schönlein purpura and juvenile idiopathic arthritis in children. He has led 5 municipal and bureau-level research projects, with cumulative research funding exceeding 1 million RMB. He has published over 30 papers, including 6 SCI-indexed articles.